Sarah Cannon Research Institute (SCRI) posted on LinkedIn:
“Introducing Ivy, a remarkable woman from Mississippi whose battle with stage IV malignant melanoma brought her to SCRI Oncology Partners.
Under the care of Dr. Meredith McKean, Ivy participated in a clinical trial that targeted her specific genetic mutations. Her determination, combined with expert care, led to her being cancer-free and enjoying life with her family.
Ivy’s journey underscores the impact of innovative cancer treatments and the dedication of our healthcare professionals.”